ATE319699T1 - Mannitol- und glucitolderivate - Google Patents

Mannitol- und glucitolderivate

Info

Publication number
ATE319699T1
ATE319699T1 AT03028655T AT03028655T ATE319699T1 AT E319699 T1 ATE319699 T1 AT E319699T1 AT 03028655 T AT03028655 T AT 03028655T AT 03028655 T AT03028655 T AT 03028655T AT E319699 T1 ATE319699 T1 AT E319699T1
Authority
AT
Austria
Prior art keywords
mannitol
glucitol derivatives
oligomeric compounds
glucitol
derivatives
Prior art date
Application number
AT03028655T
Other languages
English (en)
Inventor
Frank Dr Bergmann
Der Eltz Herbert Dr Von
Christoph Dr Seidel
Kurt Dr Weindel
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP02028714A external-priority patent/EP1431297A1/de
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE319699T1 publication Critical patent/ATE319699T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
AT03028655T 2002-12-20 2003-12-16 Mannitol- und glucitolderivate ATE319699T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02028714A EP1431297A1 (de) 2002-12-20 2002-12-20 Mannitol- und Glucitolderivate
US44021203P 2003-01-15 2003-01-15
EP03001215 2003-01-20

Publications (1)

Publication Number Publication Date
ATE319699T1 true ATE319699T1 (de) 2006-03-15

Family

ID=32600614

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03028655T ATE319699T1 (de) 2002-12-20 2003-12-16 Mannitol- und glucitolderivate

Country Status (7)

Country Link
EP (1) EP1431298B1 (de)
JP (1) JP4169689B2 (de)
CN (1) CN1513849B (de)
AT (1) ATE319699T1 (de)
CA (1) CA2453382C (de)
DE (1) DE60303865T2 (de)
ES (1) ES2260569T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2370450A1 (de) 2008-11-27 2011-10-05 Roche Diagnostics GmbH Gezielte synthese von oligophosphoramidatstereoisomeren
MX2012003396A (es) 2009-09-16 2012-04-10 Genentech Inc Complejos de proteina conteniendo helice super-enrollada y/o enlazador tether y usos de los mismos.
TW201138821A (en) 2010-03-26 2011-11-16 Roche Glycart Ag Bispecific antibodies
JP5766296B2 (ja) 2010-12-23 2015-08-19 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft ポリペプチド−ポリヌクレオチド複合体、およびエフェクター成分の標的化された送達におけるその使用
CN103384825B (zh) 2010-12-23 2017-05-24 霍夫曼-拉罗奇有限公司 通过二价结合剂检测经翻译后修饰的多肽
WO2012085113A1 (en) 2010-12-23 2012-06-28 Roche Diagnostics Gmbh Binding agent
CN104105711B (zh) 2012-02-10 2018-11-30 弗·哈夫曼-拉罗切有限公司 单链抗体及其他异多聚体
EP2867253B1 (de) 2012-06-27 2016-09-14 F. Hoffmann-La Roche AG Verfahren zur auswahl und herstellung massgeschneiderter, hochselektiver und multispezifischer targeting-einheiten mit mindestens zwei verschiedenen bindungseinheiten sowie verwendungen davon
MX2014014804A (es) 2012-06-27 2015-02-12 Hoffmann La Roche Metodo para la elaboracion de conjugados de la region fc de anticuerpos que comprenden por lo menos una entidad de union que se une especificamente a un objetivo y usos del mismo.
CN107001482B (zh) 2014-12-03 2021-06-15 豪夫迈·罗氏有限公司 多特异性抗体
EP3484908A4 (de) 2016-07-15 2020-04-08 AM Chemicals Llc Nicht-nukleosidische feste träger und phosphoramiditbausteine für die oligonukleotidsynthese

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1158618A (zh) * 1994-08-17 1997-09-03 雷加Vzw基金会 核酸序列专一性结合寡聚体及其在反义方法中的用途
DE10044373A1 (de) * 2000-09-08 2002-03-21 Roche Diagnostics Gmbh Neues Reagenz zur Markierung von Nukleinsäuren

Also Published As

Publication number Publication date
DE60303865D1 (de) 2006-05-04
DE60303865T2 (de) 2006-09-21
CA2453382A1 (en) 2004-06-20
JP4169689B2 (ja) 2008-10-22
EP1431298A1 (de) 2004-06-23
CA2453382C (en) 2009-04-07
CN1513849B (zh) 2013-03-27
ES2260569T3 (es) 2006-11-01
HK1066222A1 (en) 2005-03-18
JP2004203878A (ja) 2004-07-22
EP1431298B1 (de) 2006-03-08
CN1513849A (zh) 2004-07-21

Similar Documents

Publication Publication Date Title
ATE330038T1 (de) Nukleinsäure-biosensor
DE602004010848D1 (de) Derivate von 1-piperazin- und 1-homopiperazincarboxylaten, verfahren zu deren herstellung und deren verwendung als inhibitoren des faah-enzyms
DK1831362T3 (da) Syreaktive svampeproteaser
ATE417127T1 (de) Nukelinsäuresequenzbestimmung mittels elektronischem nachweis
NO20044290L (no) Fremgangsmate for forbedring av boredybdemalinger
DE50113023D1 (de) Verfahren zur Konditionierung von organischen Pigmenten
EP1943348A4 (de) Zusammensetzungen, verfahren und kits zur amplifikation von nukleinsäuren
ATE534629T1 (de) Verfahren und verbindungen zur herstellung von cc-1065-analoga
DE602005015834D1 (de) 3,4-(cyclopentyl)kondensierte prolinverbindungen als inhibitoren der ns3-serinprotease des hepatitis-c-virus
ATE396731T1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
AU2001244677A1 (en) Method of amplifying nucleic acid by using double-stranded nucleic acid as template
BR0101493B1 (pt) mÉtodo para transcriÇço reversa e amplificaÇço de um rna usando dna polimerases mutantes.
DE60303865D1 (de) Mannitol- und Glucitolderivate
DE60235005D1 (de) Nachweis der instabilität von mikrosatelliten und
DE602004017486D1 (de) Substituierte heteroarylbenzofuransäuren
DE60307710D1 (de) Verfahren zur Herstellung von Eisenoxiden
EE200300397A (et) Epotilooni derivaadid refraktaarsete kasvajate raviks
NO20053206D0 (no) Fremgangsmate for produsering av ketokarotenoider ved dyrking av genetisk modifiserte organismer.
ATE421501T1 (de) 2,7-substituierte 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octanamid derivate als renin inhibitoren zur behandlung von bluthochdruck
DE602005020062D1 (de) Lyophilisierung von virosomen
ATE495243T1 (de) Verfahren zur herstellung von hochempfindlichen endonukleasen, neuartige zubereitungen von nukleasen und ihre verwendung
BRPI0408117A (pt) compostos heterocìclicos bifuncionais e métodos de produção e uso dos mesmos
DE60233589D1 (de) Verfahren zur herstellung von echinocandinderivaten
DE502004009152D1 (de) Verfahren zur herstellung von derivaten des 4a,5,9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins
DE60210778D1 (de) Verfahren zur herstellung von 4-amino-2,5-bisheterocyclylchinazolinen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1431298

Country of ref document: EP